Cell Penetrable Humanized-VH/VHH That Inhibit RNA Dependent RNA Polymerase (NS5B) of HCV

Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics

(2013) John E Tavis et al.   Genome Medicine

Humanized-Single Domain Antibodies (VH/VHH) that Bound Specifically to Naja kaouthia Phospholipase A2 and Neutralized the Enzymatic Activity

(2012) Charnwit Chavanayarn et al.   Toxins

Characterization of Resistance to the Nonnucleoside NS5B Inhibitor Filibuvir in Hepatitis C Virus-Infected Patients

(2011) Philip J. F. Troke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Botulinum Neurotoxins and Botulism: A Novel Therapeutic Approach

(2011) Jeeraphong Thanongsaksrikul et al.   Toxins

A Human Single Chain Transbody Specific to Matrix Protein (M1) Interferes with the Replication of Influenza A Virus

(2010) Ornnuthchar Poungpair et al.   BIOCONJUGATE CHEMISTRY

Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin

(2009) Kasem Kulkeaw et al.   Journal of Proteomics

Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors

(2008) K. J. Herlihy et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY